Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913471 · ClinicalTrials.gov registry record
Biomarkers for Pain in Spinal Cord Injury (SCI) Patients
A clinical trial of Neuropathic Pain and Traumatic Spinal Cord Injury, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT00913471: Active study of Neuropathic Pain and Traumatic Spinal Cord Injury, sponsored by The University of Texas Health Science Center, Houston.
NCT00913471 is a study of Neuropathic Pain and Traumatic Spinal Cord Injury that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 120 participants, above the 98-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00913471, a study of Neuropathic Pain and Traumatic Spinal Cord Injury, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these biomarkers manifest. Our working hypothesis is that sustained alterations in specific inflammatory molecules are associated with chronic neuropathic pain following SCI, and that their plasma levels can serve as biomarkers to identify patients at risk for the development of neuropathic pain. Additionally the investigators are collecting skin tissue biopsy samples from patients following acute and chronic spinal cord injury to create vector-free human iPS cells from fibroblasts by direct delivery of reprogramming proteins.
Conditions Studied
Interventions
- OTHER blood samples
Study Locations (1)
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-06 |
| Est. Completion | 2030-12 |
What the registry record for NCT00913471 still lists
NCT00913471 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (22% higher).
The record links to 2 conditions, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which blood samples is the first listed.
NCT00913471 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00913471 about?
NCT00913471 is a clinical study titled "Biomarkers for Pain in Spinal Cord Injury (SCI) Patients". The investigators propose to compare plasma protein profiles for SCI patients with/without chronic neuropathic pain in order identify biomarker(s) that are associated with this medical condition. Secondly, the investigators propose to identify a temporal relationship to initial SCI at which these bi...
What is the current status of trial NCT00913471?
This trial is currently active not recruiting. The enrollment target is 120 participants. The study started on 2009-06. Estimated completion is 2030-12.
What conditions does trial NCT00913471 study?
This clinical trial studies the following conditions: Neuropathic Pain, Traumatic Spinal Cord Injury.
What interventions are being tested in trial NCT00913471?
The interventions under investigation include: blood samples (OTHER).
Who is sponsoring clinical trial NCT00913471?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00913471 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00913471's enrollment target sits among peer trials
120 8th of 35 higher than 27 of 35 other Neuropathic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neuropathic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
RECRUITING · Phase 1
-
Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study
RECRUITING
-
Diabetic Neuropathy in Spinal Cord Stimulator Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia